Ezh2, a novel target in detection and therapy of breast cancer.

about

Ezh2, a novel target in detection and therapy of breast cancer.

Item

http://www.wikidata.org/entity/Q42345199

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ezh2, a novel target in detection and therapy of breast cancer.

@en

Ezh2, a novel target in detection and therapy of breast cancer.

@nl

type

Item

label

Ezh2, a novel target in detection and therapy of breast cancer.

@en

Ezh2, a novel target in detection and therapy of breast cancer.

@nl

prefLabel

Ezh2, a novel target in detection and therapy of breast cancer.

@en

Ezh2, a novel target in detection and therapy of breast cancer.

@nl

P1476

Ezh2, a novel target in detection and therapy of breast cancer.

@en

P2093

Anthony D Accurso

http://www.w3.org/2001/XMLSchema#string

Faris Farassati

http://www.w3.org/2001/XMLSchema#string

Sarah Pourakbar

http://www.w3.org/2001/XMLSchema#string

Timothy J Pluard

http://www.w3.org/2001/XMLSchema#string

P2860

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Cancer statistics, 2013

The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression

Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.

High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer

EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.

EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

P304

2685-2687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2147/OTT.S138777

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28579806

http://www.w3.org/2001/XMLSchema#string

P932

5449122

http://www.w3.org/2001/XMLSchema#string